About James Campbell, M.D.
Form D filings for Centrexion Therapeutics from 2022 to 2024 list James Campbell, M.D. as executive officer and director.
James Campbell, M.D. first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name James Campbell, M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Campbell, M.D. works with at each company, as listed on that company's latest Form D.
Centrexion Therapeutics Corp · Form D, Jan 8, 2024
ST
Shawn Tomasello
Director
MW
Michael Ward
Chief Financial Officer, Treasurer, and Secretary
SD
Sol Barer, Ph.D.
Director
CH
Colin Hill
Director
RS
Randall Stevens
Executive officer
JS
Joseph Swedish
Director
JK
Jeffrey Kindler
Executive officer and director
JD
J.c. Lopez, M.D.
Director